Reactive Vapors in the Nasal Cavity

Physiologically Based Pharmacokinetic Modeling: Science and Applications

Volumn , Issue , 2005, Pages 119-140

  Dennison, James E ^a   Andersen, Melvin E ^b  

^a Department of Environmental and Radiological Health Sciences   (United States)

^b CIIT CENTERS FOR HEALTH RESEARCH   (United States)

Author keywords

Computational fluid dynamics; DNA adduct formation; Esters; Formaldehyde; Nasal airways; Organic acids; PBPK CFD models; Pharmacodynamic models; Protein adduct formation; Reference concentration estimations; Respiratory tract; RfC estimations; Risk assessment

Indexed keywords

EID: 84890616409     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/0471478768.ch5     Document Type: Chapter

References (39)

1. Aharonson, E. F., Menkes, H., Gurtner, G., Swift, D. L., and Proctor, D. F. (1974). Effect of respiratory airflow rate on removal of soluble vapors by the nose. J. Appl. Physiol. 37, 654-657.
2. Andersen, M. E., and Sarangapani, R. (1999). Clearance concepts applied to the metabolism of inhaled vapors in tissues lining the nasal cavity. Inhal. Toxicol. 11, 873-897.
3. Andersen, M. E., and Sarangapani, R. (2001). Physiologically based clearance/extraction models for compounds metabolized in the nose: An example with methyl methacrylate. Inhal. Toxicol. 13, 397-414.
4. Andersen, M. E., Sarangapani, R., Frederick, C. B., and Kimbell, J. S. (1999). Dosimetric adjustment factors for methyl methacrylate derived from a steady-state analysis of a physiologically based clearance-extraction model. Inhal. Toxicol. 11, 899-926.
5. Andersen, M., Sarangapani, R., Gentry, R., Clewell, H., Covington, T., and Frederick, C. B. (2000). Application of a hybrid CFD-PBPK nasal dosimetry model in an inhalation risk assessment: An example with acrylic acid. Toxicol. Sci. 57, 312-325.
6. Bogdanffy, M. S., and Sarangapani, R. (2003). Physiologically-based kinetic modeling of vapours toxic to the respiratory tract. Toxicol. Lett. 138, 103-117.
7. Bogdanffy, M. S., Sarangapani, R., Kimbell, J. S., Frame, S. R., and Plowchalk, D. R. (1998). Analysis of vinyl acetate metabolism in rat and human nasal tissues by an in vitro gas uptake technique. Toxicol. Sci. 46, 235-246.
8. Bogdanffy, M. S., Sarangapani, R., Plowchalk, D. R., Jarabek, A., and Andersen, M. E. (1999a). A biologically based risk assessment for vinyl acetate-induced cancer and noncancer inhalation toxicity. Toxicol. Sci. 51, 19-35.
9. Bogdanffy, M. S., Manning, L. A., and Sarangapani, R. (1999b). High-affinity nasal extraction of vinyl acetate vapor is carboxylesterase dependent. Inhal. Toxicol. 11, 927-941.
10. Bush, M. L., Frederick, C. B., Kimbell, J. S., and Ultman, J. S. (1998). CFD-PBPK hybrid model for simulating gas and vapor uptake in the rat nose. Toxicol. Appl. Pharmacol. 150, 133-145.
11. Casanova, M., Morgan, K. T., Steinhagen, W. H., Everitt, J. I., Popp, J. A., and Heck, H. D. (1991). Covalent binding of inhaled formaldehyde to DNA in the respiratory tract of rhesus monkeys: Pharmacokinetics, rat-to-monkey interspecies scaling, and extrapolation to man. Fundam. Appl. Toxicol. 17, 409-428.
12. Conolly, R. B., Lilly, P. D., and Kimbell, J. S. (2000). Simulation modeling of the tissue disposition of formaldehyde to predict nasal DNA-protein cross-links in Fischer 344 rats, rhesus monkeys, and humans. Environ. Health Perspect. 108(Suppl 5), 919-924.
13. Conolly, R. B., Kimbell, J. S., Janszen, D. B., and Miller, F. J. (2002). Dose response for formaldehydeinduced cytotoxicity in the human respiratory tract. Regul. Toxicol. Pharmacol. 35, 32-43.
14. Conolly, R. B., Kimbell, J. S., Janszen, D., Schlosser, P. M., Kalisak, D., Preston, J., and Miller, F. J. (2003). Biologically motivated computational modeling of formaldehyde carcinogenicity in the F344 rat. Toxicol. Sci. 75, 432-447.
15. Frederick, C. B., Bush, M. L., Lomax, L. G., Black, K. A., Finch, L., Kimbell, J. S., Morgan, K. T., Subramaniam, R. P., Morris, J. B., and Ultman, J. S. (1998). Application of a hybrid computational fluid dynamics and physiologically based inhalation model for interspecies dosimetry extrapolation of acidic vapors in the upper airways. Toxicol. Appl. Pharmacol. 152, 211-231.
16. Frederick, C. B., Potter, D. W., Chang-Mateu, M. I., and Andersen, M. E. (1992). A physiologically based pharmacokinetic and pharmacodynamic model to describe the oral dosing of rats with ethyl acrylate and its implications for risk assessment. Toxicol. Appl. Pharmacol. 114, 246-260.
17. Frederick, C. B., Gentry, P. R., Bush, M. L., Lomax, L. G., Black, K. A., Finch, L., Kimbell, J. S., Morgan, K. T., Subramaniam, R. P., Morris, J. B., and Ultman, J. S. (2001). Ahybrid computational fluid dynamics and physiologically based pharmacokinetic model for comparison of predicted tissue concentrations of acrylic acid and other vapors in the rat and human nasal cavities following inhalation exposure. Inhal. Toxicol. 13, 359-376.
18. Frederick, C. B., Lomax, L. G., Black, K. A., Finch, L., Scribner, H. E., Kimbell, J. S., Morgan, K. T., Subramaniam, R. P., and Morris, J. B. (2002). Use of a hybrid computational fluid dynamics and physiologically based inhalation model for interspecies dosimetry comparisons of ester vapors. Toxicol. Appl. Pharmacol. 183, 23-40.
19. Gerde, P., and Dahl, A. R. (1991). A model for the uptake of inhaled vapors in the nose of the dog during cyclic breathing. Toxicol. Appl. Pharmacol. 109, 276-288.
20. Ginsberg, G. L., Pepelko, W. E., Goble, R. L., and Hattis, D. B. (1996). Comparison of contact site cancer potency across dose routes: case study with epichlorohydrin. Risk Anal. 16, 667-681.
21. Hubal, E. A., Schlosser, P. M., Conolly, R. B., and Kimbell, J. S. (1997). Comparison of inhaled formaldehyde dosimetry predictions with DNA-protein cross-link measurements in the rat nasal passages. Toxicol. Appl. Pharmacol. 143, 47-55.
22. Kelly, J. T., Kimbell, J. S., and Asgharian, B. (2001). Deposition of fine and coarse aerosols in a rat nasal mold. Inhal. Toxicol. 13, 577-588.
23. Kimbell, J. S., and Subramaniam, R. P. (2001). Use of computational fluid dynamics models for dosimetry of inhaled gases in the nasal passages. Inhal. Toxicol. 13, 325-334.
24. Kimbell, J. S., Gross, E. A., Joyner, D. R., Godo, M. N., and Morgan, K. T. (1993). Application of computational fluid dynamics to regional dosimetry of inhaled chemicals in the upper respiratory tract of the rat. Toxicol. Appl. Pharmacol. 121, 253-263.
25. Kimbell, J. S., Overton, J. H., Subramaniam, R. P., Schlosser, P. M., Morgan, K. T., Conolly, R. B., and Miller, F. J. (2001a). Dosimetry modeling of inhaled formaldehyde: Binning nasal flux predictions for quantitative risk assessment. Toxicol. Sci. 64, 111-121.
26. Kimbell, J. S., Subramaniam, R. P., Gross, E. A., Schlosser, P. M., and Morgan, K. T. (2001b). Dosimetry modeling of inhaled formaldehyde: Comparisons of local flux predictions in the rat, monkey, and human nasal passages. Toxicol. Sci. 64, 100-110.
27. Miller, F. J., Overton, J. H., Jr., Jaskot, R. H., and Menzel, D. B. (1985). A model of the regional uptake of gaseous pollutants in the lung. I. The sensitivity of the uptake of ozone in the human lung to lower respiratory tract secretions and exercise. Toxicol. Appl. Pharmacol. 79, 11-27.
28. Morris, J. B., Hassett, D. N., and Blanchard, K. T. (1993). Aphysiologically based pharmacokinetic model for nasal uptake and metabolism of nonreactive vapors. Toxicol. Appl. Pharmacol. 123, 120-129.
29. Moulin, F. J., Brenneman, K. A., Kimbell, J. S., and Dorman, D. C. (2002). Predicted regional flux of hydrogen sulfide correlates with distribution of nasal olfactory lesions in rats. Toxicol. Sci. 66, 7-15.
30. Overton, J. H. (1990). A respiratory tract dosimetry model for air toxics. Toxicol. Ind. Health 6, 171-180.
31. Overton, J. H. (2001). Dosimetry modeling of highly soluble reactive gases in the respiratory tract. Inhal. Toxicol. 13, 347-357.
32. Overton, J. H., Graham, R. C., and Miller, F. J. (1987). A model of the regional uptake of gaseous pollutants in the lung. II. The sensitivity of ozone uptake in laboratory animal lungs to anatomical and ventilatory parameters. Toxicol. Appl. Pharmacol. 88, 418-432.
33. Overton, J. H., Kimbell, J. S., and Miller, F. J. (2001). Dosimetry modeling of inhaled formaldehyde: The human respiratory tract. Toxicol. Sci. 64, 122-134.
34. Pang, K. S., and Rowland, M. (1977). Hepatic clearance of drugs. I. Theoretical considerations of a "wellstirred" model and a "parallel-tube" model. Influence of hepatic blood flow, plasma and blood cell binding, and hepatocellular enzymatic activity on hepatic drug clearance. J. Pharmacokinet. Biopharm. 5, 625-653.
35. Plowchalk, D. R., Andersen, M. E., and Bogdanffy, M. S. (1997). Physiologically based modeling of vinyl acetate uptake, metabolism, and intracellular pH changes in the rat nasal cavity. Toxicol. Appl. Pharmacol. 142, 386-400.
36. Schlosser, P. M., Lilly, P. D., Conolly, R. B., Janszen, D. B., and Kimbell, J. S. (2003). Benchmark dose risk assessment for formaldehyde using airflow modeling and a single-compartment, DNA-protein cross-link dosimetry model to estimate human equivalent doses. Risk Anal. 23, 473-487.
37. Subramaniam, R. P., Richardson, R. B., Morgan, K. T., and Kimbell, J. S. (1998). Computational fluid dynamics simulations of inspiratory airflow in the human nose and nasopharynx. Inhal. Toxicol. 10, 91-120.
38. Sweeney, L. M., Andersen, M. E., and Gargas, M. L. (2004). Ethyl acrylate risk assessment with a hybrid computational fluid dynamics and physiologically based nasal dosimetry model. Toxicol. Sci. 79, 394-403.
39. US EPA (1994). Methods of Derivation of Inhalation Reference Concentrations and Application of Inhalation Dosimetry, U.S. Environmental Protection Agency, Office of Research and Development, Office of Health and Environmental Assessment, Washington, D.C., EPA/600/8-90/066F.